These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22424612)

  • 1. Synthesis, modeling and functional activity of substituted styrene-amides as small-molecule CXCR7 agonists.
    Wijtmans M; Maussang D; Sirci F; Scholten DJ; Canals M; Mujić-Delić A; Chong M; Chatalic KL; Custers H; Janssen E; de Graaf C; Smit MJ; de Esch IJ; Leurs R
    Eur J Med Chem; 2012 May; 51():184-92. PubMed ID: 22424612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mode of binding of the cyclic agonist peptide TC14012 to CXCR7: identification of receptor and compound determinants.
    Montpas N; Cabana J; St-Onge G; Gravel S; Morin G; Kuroyanagi T; Lavigne P; Fujii N; Oishi S; Heveker N
    Biochemistry; 2015 Feb; 54(7):1505-15. PubMed ID: 25669416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCR7 agonists inhibit the function of CXCL12 by down-regulation of CXCR4.
    Uto-Konomi A; McKibben B; Wirtz J; Sato Y; Takano A; Nanki T; Suzuki S
    Biochem Biophys Res Commun; 2013 Feb; 431(4):772-6. PubMed ID: 23333329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of novel CXC chemokine receptor 7 (CXCR7) ligands: selectivity switch from CXCR4 antagonists with a cyclic pentapeptide scaffold.
    Oishi S; Kuroyanagi T; Kubo T; Montpas N; Yoshikawa Y; Misu R; Kobayashi Y; Ohno H; Heveker N; Furuya T; Fujii N
    J Med Chem; 2015 Jul; 58(13):5218-25. PubMed ID: 26042340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymmetric Synthesis of a Potent CXCR7 Modulator Featuring a Hindered Tertiary β-Amino Amide Stereocenter.
    Canterbury DP; Godin F; Desjardins S; Bayrakdarian M; Albert JS; Perry DA; Hesp KD
    Org Lett; 2018 Sep; 20(17):5336-5339. PubMed ID: 30118238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands.
    Zabel BA; Wang Y; Lewén S; Berahovich RD; Penfold ME; Zhang P; Powers J; Summers BC; Miao Z; Zhao B; Jalili A; Janowska-Wieczorek A; Jaen JC; Schall TJ
    J Immunol; 2009 Sep; 183(5):3204-11. PubMed ID: 19641136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human herpesvirus 8-encoded chemokine vCCL2/vMIP-II is an agonist of the atypical chemokine receptor ACKR3/CXCR7.
    Szpakowska M; Dupuis N; Baragli A; Counson M; Hanson J; Piette J; Chevigné A
    Biochem Pharmacol; 2016 Aug; 114():14-21. PubMed ID: 27238288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and evaluation of non-basic small molecule modulators of the atypical chemokine receptor CXCR7.
    Aspnes GE; Menhaji-Klotz E; Boehm M; Londregan AT; Lee ECY; Limberakis C; Coffey SB; Brown JA; Jones RM; Hesp KD
    Bioorg Med Chem Lett; 2021 Oct; 50():128320. PubMed ID: 34400299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of the Potent, Selective, Orally Available CXCR7 Antagonist ACT-1004-1239.
    Richard-Bildstein S; Aissaoui H; Pothier J; Schäfer G; Gnerre C; Lindenberg E; Lehembre F; Pouzol L; Guerry P
    J Med Chem; 2020 Dec; 63(24):15864-15882. PubMed ID: 33314938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCR7 ameliorates myocardial infarction as a β-arrestin-biased receptor.
    Ishizuka M; Harada M; Nomura S; Ko T; Ikeda Y; Guo J; Bujo S; Yanagisawa-Murakami H; Satoh M; Yamada S; Kumagai H; Motozawa Y; Hara H; Fujiwara T; Sato T; Takeda N; Takeda N; Otsu K; Morita H; Toko H; Komuro I
    Sci Rep; 2021 Feb; 11(1):3426. PubMed ID: 33564089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational analysis of the extracellular disulphide bridges of the atypical chemokine receptor ACKR3/CXCR7 uncovers multiple binding and activation modes for its chemokine and endogenous non-chemokine agonists.
    Szpakowska M; Meyrath M; Reynders N; Counson M; Hanson J; Steyaert J; Chevigné A
    Biochem Pharmacol; 2018 Jul; 153():299-309. PubMed ID: 29530506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimized method of G-protein-coupled receptor homology modeling: its application to the discovery of novel CXCR7 ligands.
    Yoshikawa Y; Oishi S; Kubo T; Tanahara N; Fujii N; Furuya T
    J Med Chem; 2013 Jun; 56(11):4236-51. PubMed ID: 23656360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-Arrestin-2 Counters CXCR7-Mediated EGFR Transactivation and Proliferation.
    Kallifatidis G; Munoz D; Singh RK; Salazar N; Hoy JJ; Lokeshwar BL
    Mol Cancer Res; 2016 May; 14(5):493-503. PubMed ID: 26921391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of Amantamide, a Selective CXCR7 Agonist from Marine Cyanobacteria.
    Liang X; Luo D; Yan JL; Rezaei MA; Salvador-Reyes LA; Gunasekera SP; Li C; Ye T; Paul VJ; Luesch H
    Org Lett; 2019 Mar; 21(6):1622-1626. PubMed ID: 30779584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCR7 impact on CXCL12 biology and disease.
    Sánchez-Martín L; Sánchez-Mateos P; Cabañas C
    Trends Mol Med; 2013 Jan; 19(1):12-22. PubMed ID: 23153575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The presumed atypical chemokine receptor CXCR7 signals through G(i/o) proteins in primary rodent astrocytes and human glioma cells.
    Odemis V; Lipfert J; Kraft R; Hajek P; Abraham G; Hattermann K; Mentlein R; Engele J
    Glia; 2012 Mar; 60(3):372-81. PubMed ID: 22083878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCR7 prevents excessive CXCL12-mediated downregulation of CXCR4 in migrating cortical interneurons.
    Abe P; Mueller W; Schütz D; MacKay F; Thelen M; Zhang P; Stumm R
    Development; 2014 May; 141(9):1857-63. PubMed ID: 24718993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-Activity Relationship Study of Cyclic Pentapeptide Ligands for Atypical Chemokine Receptor 3 (ACKR3).
    Sekiguchi H; Kuroyanagi T; Rhainds D; Kobayashi K; Kobayashi Y; Ohno H; Heveker N; Akaji K; Fujii N; Oishi S
    J Med Chem; 2018 Apr; 61(8):3745-3751. PubMed ID: 29608300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common structural interactions between the receptors CXCR3, CXCR4 and CXCR7 complexed with their natural ligands, CXCL11 and CXCL12, by a modeling approach.
    Costantini S; Raucci R; De Vero T; Castello G; Colonna G
    Cytokine; 2013 Oct; 64(1):316-21. PubMed ID: 23773308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of Diphenylacetamides as CXCR7 Inhibitors with Novel β-Arrestin Antagonist Activity.
    Menhaji-Klotz E; Ward J; Brown JA; Loria PM; Tan C; Hesp KD; Riccardi KA; Litchfield J; Boehm M
    ACS Med Chem Lett; 2020 Jun; 11(6):1330-1334. PubMed ID: 32551020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.